NCT01653717 CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE1
NCT01563302 Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT01532011 Erlotinib in Combination With Pralatrexate in Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01529593 Temsirolimus in Combination With Metformin in Patients With Advanced Cancers Status TERMINATED Phase PHASE1
NCT01515566 Breakthrough Dyspnea Fentanyl Study in Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT01454804 Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01430572 Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients Status COMPLETED Phase PHASE1
NCT01389830 End of Life Treatment Preferences of Latino Medicare Beneficiaries With Cancer Status UNKNOWN Phase N/A
NCT01375114 The Effects of Ginseng on Cancer-Related Fatigue Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01277744 Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor Status COMPLETED Phase PHASE2
NCT01266057 Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer Status COMPLETED Phase PHASE1
NCT01259284 Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT01213238 Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab Status COMPLETED Phase PHASE1
NCT01201694 Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L) Status COMPLETED Phase PHASE1
NCT01200004 Study of Grifola Frondosa (Maitake), Azacitidine, and Lenalidomide Status TERMINATED Phase PHASE1